Metabolic milieu associates with impaired skeletal characteristics in obesity

PLoS One. 2017 Jun 22;12(6):e0179660. doi: 10.1371/journal.pone.0179660. eCollection 2017.

Abstract

High leptin concentration, low-grade inflammation, and insulin resistance often coexist in obese subjects; this adverse metabolic milieu may be the main culprit for increased fracture risk and impaired bone quality seen in patients with type 2 diabetes. We examined the associations of leptin, hs (high sensitivity)- CRP and insulin resistance with bone turnover markers (BTMs) and bone characteristics in 55 young obese adults (median BMI 40 kg/m2) and 65 non-obese controls. Mean age of the subjects was 19.5 ± 2.5 years (mean ± SD). Concentrations of leptin, adiponectin, hs-CRP, MMP-8 and TIMP-1, fasting plasma glucose and insulin (to calculate HOMA), BTMs (BAP, P1NP, CTX-1, and TRAC5b) were measured. Bone characteristics were determined with pQCT at radius and tibia, and with DXA for central sites. Leptin, hs-CRP and HOMA correlated inversely with BTMs: the partial coefficients were 1.5-1.9 fold higher in males than in females. After adjusting for age, BMI, and other endocrine factors, leptin displayed an independent effect in males on radial bone mass (p = 0.019), tibial trabecular density (p = 0.025) and total hip BMD (p = 0.043), with lower densities in males with high leptin. In females, the model adjusting for age, BMI, and other endocrine factors, revealed that hs-CRP had independent effects on radial bone mass (p = 0.034) and lumbar spine BMD (p = 0.016), women with high hs-CRP having lower values. Partial correlations of adiponectin and TIMP-1 with bone characteristics were discrepant; MMP-8 showed no associations. In conclusion, in young obese adults and their controls, leptin, hs-CRP and HOMA associate inversely with BTMs and bone characteristics. Leptin appears to be the key independent effector in males, whereas hs-CRP displayed a predominant role in females.

MeSH terms

  • Adolescent
  • Adult
  • Bone and Bones / diagnostic imaging
  • Bone and Bones / metabolism*
  • Bone and Bones / physiopathology
  • C-Reactive Protein / metabolism
  • Case-Control Studies
  • Child
  • Female
  • Humans
  • Insulin Resistance
  • Leptin / metabolism
  • Male
  • Obesity, Morbid / diagnostic imaging
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / physiopathology
  • Tomography, X-Ray Computed
  • Young Adult

Substances

  • Leptin
  • C-Reactive Protein

Grants and funding

This study was supported by funds from the Academy of Finland (grant number 277843, 258753), Sigrid Jusélius Foundation, Foundation for Pediatric Research, Folkhälsan Research Foundation, Novo Nordisk Foundation, Swedish Research Council, Swedish Childhood Cancer Foundation, Ahokas Foundation, Finska Läkaresällskapet, and Liv och Hälsa Foundation, and Helsinki University Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.